RECURRENT EPITHELIAL OVARIAN CANCER
Clinical trials for RECURRENT EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets Hard-to-Treat ovarian cancers
Disease control OngoingThis early-phase trial tests a new immune cell therapy called FT536 for people with recurrent ovarian, fallopian tube, or primary peritoneal cancer. The treatment is given directly into the abdomen after a short course of chemotherapy. Only 3 participants are enrolled, so the mai…
Matched conditions: RECURRENT EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug duo aims to stall ovarian Cancer's return
Disease control OngoingThis phase 2 trial is testing whether adding oregovomab (an antibody) to niraparib (a daily pill) can better control platinum-sensitive recurrent ovarian cancer. Ten women whose cancer came back after initial chemotherapy will receive both drugs for 12 weeks. The main goal is to …
Matched conditions: RECURRENT EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC